Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2007

Open Access 01-12-2007 | Research article

Metabolic syndrome in a Taiwanese metropolitan adult population

Authors: Cheng-Chieh Lin, Chiu-Shong Liu, Ming-May Lai, Chia-Ing Li, Ching-Chu Chen, Pei-Chia Chang, Wen-Yuan Lin, Yih-Dar Lee, Tsann Lin, Tsai-Chung Li

Published in: BMC Public Health | Issue 1/2007

Login to get access

Abstract

Background

Metabolic syndrome (MS) is a combination of medical disorders that increase one's risk for cardiovascular disease and diabetes. Little information exists on the prevalence of MS in a general adult population in Taiwan.

Methods

We did a cross-sectional survey in a representative sample of 2,359 Chinese adults aged 40 years and over who lived in a metropolitan city, Taiwan in 2004–05. MS was defined by Adult Treatment Panel III criteria modified for Asians.

Results

The prevalence of MetS was 35.32% and 43.23% in men aged 40–64 years and 65 years and over, respectively, and 24.19% and 51.82% in women aged 40–64 years and 65 years and over. Older age, postmenopausal status, higher body mass index, current smoking, low education attainment, low household income, no alcohol consumption, lower level of occupation physical activity, and a family history of diabetes were associated with increased odds of MetS.

Conclusion

MetS was present in more than 30% of the Taiwan adult population aged 40 years and over in a metropolitan area; there were substantial variations by age and body mass index groups.
Literature
1.
Department of Health, The Executive Yuan, ROC: Statistics Report, Republic of China. 2005
2.
Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004, 140: 167-74.CrossRefPubMed
3.
Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001, 24: 683-89. 10.2337/diacare.24.4.683.CrossRefPubMed
4.
Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-97. 10.1001/jama.285.19.2486.
5.
Onat A, Ceyhan K, Başcar O, Erer B, Toprak S, Sansoy V: Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels – a prospective and cross-sectional evaluation. Atherosclerosis. 2002, 165 (2): 285-92. 10.1016/S0021-9150(02)00236-8.CrossRefPubMed
6.
Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, Whelton PK, He J, InterASIA Collaborative Group: Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005, 365: 1398-405. 10.1016/S0140-6736(05)66375-1.CrossRefPubMed
7.
Cameron AJ, Shaw JE, Zimmet PZ: The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004, 33 (2): 351-75. 10.1016/j.ecl.2004.03.005.CrossRefPubMed
8.
Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P: Prevalence of the metabolic syndrome among Omani adults. Diabetes Care. 2003, 26 (6): 1781-5. 10.2337/diacare.26.6.1781.CrossRefPubMed
9.
Azizi F, Salehi P, Etemadi A, Zahedi-Asl S: Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2003, 61 (1): 29-37. 10.1016/S0168-8227(03)00066-4.CrossRefPubMed
10.
Gupta A, Gupta R, Sarna M, Rastogi S, Gupta VP, Kothari K: Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract. 2003, 61 (1): 69-76. 10.1016/S0168-8227(03)00085-8.CrossRefPubMed
11.
Chuang SY, Chen CH, Tsai ST, Chou P: Clinical identification of the metabolic syndrome in Kinmen. Acta Cardiol Sin. 2002, 18: 16-23.
12.
Hwang LC, Bai CH, Chen CJ: Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc. 2006, 105 (8): 626-35.CrossRefPubMed
13.
Meigs JB, Wilson PW, Nathan DM, D'Agostino RB, Williams K, Haffner SM: Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003, 52 (8): 2160-7. 10.2337/diabetes.52.8.2160.CrossRefPubMed
14.
Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB: The Metabolic Syndrome: Prevalence and associated risk factor findings in the US population from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2003, 163: 427-36. 10.1001/archinte.163.4.427.CrossRefPubMedPubMedCentral
15.
Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287 (3): 356-9. 10.1001/jama.287.3.356.CrossRefPubMed
16.
Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA: Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. 2002, 156 (11): 1070-7. 10.1093/aje/kwf145.CrossRefPubMed
17.
Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002, 288 (21): 2709-16. 10.1001/jama.288.21.2709.CrossRefPubMed
18.
Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J: The metabolic syndrome in the West Bank Population. Diabetes Care. 2001, 24 (2): 275-79. 10.2337/diacare.24.2.275.CrossRefPubMed
Metadata
Title
Metabolic syndrome in a Taiwanese metropolitan adult population
Authors
Cheng-Chieh Lin
Chiu-Shong Liu
Ming-May Lai
Chia-Ing Li
Ching-Chu Chen
Pei-Chia Chang
Wen-Yuan Lin
Yih-Dar Lee
Tsann Lin
Tsai-Chung Li
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2007
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-7-239

Other articles of this Issue 1/2007

BMC Public Health 1/2007 Go to the issue

Research article

Potential cost savings with terrestrial rabies control

Research article

Health behaviors and risk factors in those who use complementary and alternative medicine

Research article

Parents' attitudes towards hepatitis B vaccination for their children. A survey comparing paper and web questionnaires, Sweden 2005

Research article

Before and after study of bar workers' perceptions of the impact of smoke-free workplace legislation in the Republic of Ireland

Research article

Changes in body mass index by age, gender, and socio-economic status among a cohort of Norwegian men and women (1990–2001)

Research article

Prevalence and risk factors for HIV-1 infection in rural Kilimanjaro region of Tanzania: Implications for prevention and treatment